CTRI/2021/09/036158尚未招募2 期
A Randomized, Parallel Group, Active Controlled Clinical Study to Evaluate Efficacy and Safety of a Unani Pharmacopoeial Formulation â?? Iksir-i Shifa in the Management of á¸?aght al- Dam QawÄ« LÄ?zimÄ« (Essential Hypertension)
ational Research Institute of Unani Medicine for Skin Disorders0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i. Participants of any sex aged between 35-55 years
- •ii. Stage-â? Hypertension according to JNC 7 (Systolic BP 140-159 and Diastolic BP 90-99 mmHg)
- •iii. Participants willing to sign the informed consent form
排除标准
- •i. Participants with Secondary Hypertension (SBP >=160 mmHg and DBP >=100 mmHg)
- •ii. Comorbidities condition
- •iii. Pregnant and Lactating women
- •iv. Drug Addicts, Alcoholics
- •v. Participants not willing to give consent
- •vi. Participants not willing to come for follow-up
研究者
相似试验
已完成
3 期
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.CTRI/2010/091/000627Biocon SA286
Unknown
3 期
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.CTRI/2009/091/000098Biocon S.A. Fid Borruat Sarl, Sous Maichereux 20 Case postale 2027 CH-2800, Delemont, Switzerland274
进行中（未招募）
不适用
A Randomized, Active Controlled, Parallel Group, Multicentre, Two-Phase, Open-Label Study Comparing the Safety and Immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in Patients with Type 1 Diabetes MellitusType 1 Diabetes mellitusEUCTR2010-018354-12-DEBiocon S.A.286
进行中（未招募）
不适用
A Randomized, Active Controlled, Parallel Group, Multicentre, Two-Phase, Open-Label Study Comparing the Safety and Immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in Patients with Type 1 Diabetes Mellitus - NDDiabetes Mellitus Type 1MedDRA version: 9.1Level: LLTClassification code 10045228EUCTR2010-018354-12-ITBIOCON S A286
进行中（未招募）
1 期
A Phase 3b/4 Study in Rheumatoid ArthritisMedDRA version: 21.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2018-003351-37-GBEli Lilly and Company2,600